Big data is fundamentally reshaping the landscape of modern eyecare. Through clinical and consumer datasets, clinicians are moving beyond reactive care toward a proactive model. By integrating predictive analytics and real-world evidence, practitioners can now identify subtle trends and build sophisticated models that forecast patient outcomes. Rehan Ahmed, MD, and Scot Morris, OD, explore how this will shape doctors of the future.
What is Big Data?
Big data is made up of “vast data sets” that include electronic health records, retinal scans, OCTs, visual fields, tonometry, wearable sensors and insurance claims. Those sources allow predictive analytics to flag patients at risk for diabetic retinopathy, glaucoma and even nonobvious risks such as cardiovascular disease or Alzheimer’s.
Real-world evidence matters because it captures diverse, everyday clinical scenarios that clinical trials can miss. “Clinical trials have very strict inclusion and exclusion criteria,” says Dr. Ahmed, and real-world evidence shows how treatments perform outside of controlled settings. Dr. Morris pointed to retinal injections, noting that the now-common “treat and extend” protocol emerged from clinicians’ real-world experience rather than from initial trial designs.
Big data can also tailor therapy to an individual’s genetics, lifestyle and history. “Digital twins,” which are simulations built from aggregated data, could predict how a patient might respond to one drug versus another. “You could just run a simulation,” Dr. Ahmed says, to test which medication will work best for a given person.
Complications: Privacy and Access
The core challenges of big data include data quality, bias and privacy. Dr. Morris warns that flawed inputs produce flawed outputs: “Garbage in, garbage out.” He stresses the need to include data from underrepresented populations to avoid biased models and to make results generalizable. Data from hard-to-reach regions, such as Rwanda and Bangladesh, can strengthen global data sets.
Dr. Ahmed notes patients and institutions are “smartening up about their data,” and researchers cannot simply mine electronic records without patient consent. At the same time, regulation and commercial concerns are tightening access to datasets that once were freely available. “Data is the new oil,” Dr. Ahmed says, calling it “the currency of the future.”
What to Expect in the Future
Memorization will matter less for future doctors as intelligent systems bring information to clinicians when needed. Training should emphasize communication, change management, behavior modification and critical thinking. These skills are needed to translate AI-derived insights into care plans patients can understand. “The ability to connect is greater than our intellect,” Dr. Morris says.
That shift has practical implications for medical education. Dr. Ahmed also notes a future in which patients may use similar AI tools and bring their own analyses to the clinic. This makes the clinician’s role one of judgment and interpretation.
Wearable devices and consumer behavior data are an underexplored source of medical insight. Dr. Morris cites the Oura ring and smartphone sensors as untapped predictors of health that could complement clinic-based data. The end goal is a patient-centered care model in which clinicians and AI work together. “We are better together,” Dr. Morris says.
Listen to this episode of Real Talk.
For help with AI key terms, click here for our AI dictionary.
Author
